| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |